MATERIALS AND METHODS
INTRODUCTION
T emperature-gated transient receptor potential (Thermo-TRP) ion channels are cation channels highly expressed in the small nociceptive c-fibers of dorsal root ganglia (DRG) and trigeminal ganglia, with the 1st member cloned as late as 1997. 1 The expression pattern and activation profile including noxious temperatures, chemicals, protons, and inflammatory agents suggests involvement in depolarizations of primary nerve endings in response to painful stimuli. 2, 3 Therefore, during the past decade, multiple programs have been started in biotech and pharmaceutical companies to identify small-molecule antagonists targeting Thermo-TRP ion channels. 4 The 6 members of this class that have been cloned and expressed in heterologous expression systems so far are in order of in vitro temperature activation profile from cold to hot: TRPA1 (<17 °C), TRPM8 (<25 °C), TRPV4 (>25 °C), TRPV3 (>31 °C), TRPV1 (>42 °C), and TRPV2 (>52 °C). 5, 6 Together they cover the whole temperature range from noxious and tissue-damaging cold to equally noxious and damaging heat. Among these, TRPV1 was the first to be cloned using capsaicin, the pungent hot ingredient in chili peppers, as the marker of functional expression. 1 TRPV1 has also generated the most mature Thermo-TRP antagonist programs so far: Abbot, Amgen, AstraZeneca, GSK, Merck-Neurogen, Novartis, and others. 4 Novel antagonists have been discovered by modeling over agonist scaffolds, capsaicin-capsazepine, 7 radioligand-binding studies with RTX, and functional cell-based screening of chemical libraries using nonendogenous agonists such as mustard oil or capsaicin. These assays, however, display limited ability to gate Thermo-TRPs in a physiological relevant manner. [8] [9] [10] Temperature hypersensitivity (cold and/or heat allodynia) is often part of the diagnosis in chronic pain conditions. Assessing the pharmacology against the temperature activation of Thermo-TRPs is therefore important for selection and development of new pharmacological agents with putative analgesic potential. Recent studies have identified specific domains in Thermo-TRPs determining the temperature gating directly, whereas others confer voltage-or ligand-dependent activation. 11, 12 This suggests that it may be possible to separate the multiple modes of TRPV1 activation even for antagonists.
In this study, we used the ABI Prism  7900HT Sequence Detection System designed for high-throughput (96-or 384-well plates) fluorescence-based real-time PCR assays (TaqMan assays). The combination of an argon laser excitation, chargecoupled device (CCD) fluorescence detection and precise temperature control (heat/cool rate of 1.5 °C/s) enabled us to develop an assay measuring intracellular calcium-induced fluorescence in response to ramp or step temperature changes.
Invitrogen 16000-044), 5 µg/ml Blasticidin (MP Biomedicals 150477), and 350 µg/ml Zeomycin (Invitrogen 45-0430) at 37 °C in a humidified incubator with 5% CO 2 . For experiments on human TRPA1, we used the Chinese Hamster Ovary cell line (CHO-TRPA1) with T-Rex, a tetracycline/ doxycycline-inducible expression system. CHO-TRPA1 cells were cultured in Hams F12's medium (Gibco 31765) supplemented with 10 % FBS, 10 µg/ml Blasticidin, and 400 µg/ml Geneticin (GibcoBRL 11811-031). Experiments on human TRPM8 used an HEK293 cell line. Cells were cultured in MEM's medium supplemented with 1% nonessential amino acids (Gibco 11140-035), 10% FBS, 10 mM Hepes (Gibco 15630-056), 1% penicillin-streptomycin (Gibco 15140-122), and 200 µg/ml Geneticin.
Preparation of adult rat DRG neurons
DRG neurons were obtained from adult rats after decapitation while under anesthesia. DRGs were surgically removed and placed in ice-cold L-15 Leibovitz medium (Fisher Scientific 164336555). Then, whole DRGs were dissociated using fine scissors under a microscope and placed in a culture dish containing L-15 medium with collagenase (1 mg/ml, Gibco 17018-029) for 60 min and trypsin-EDTA (1 mg/ml, Gibco 15400) for an additional 30 min at 37 °C. The enzymatic dissociation was stopped by transferring the ganglia to a 50-ml tube containing L-15 medium with 10% FBS. The dissociated cells were centrifuged (1500 rpm) for 4 min, supernatant removed, resuspended in 4 ml L-15 medium, and triturated sequentially with 2-3 Pasteur pipettes of decreasing orifice size. Finally, DRGs were plated in a poly-L-lysine-treated (Sigma-Aldrich P1399) optical 96-well reaction plate (Applied Biosystems 4306737) at a concentration of ≈1000 cells/100 µL/well. The experimental procedure followed the guidelines and recommendations of Swedish Animal Protection Legislation and was approved by the South Stockholm Committee for Ethical Experiments on Laboratory Animals.
Instrumentation
The assay was set up on the ABI Prism  7900HT Sequence Detection System with SDS 2.1 software version (Applied Biosystems) designed for detection of fluorescence in realtime PCR assays (TaqMan assays). We exploited the optical system features of the 7900HT instrument: an argon laser excitation source, a CCD camera for detection of fluorescence emission between 500 nm and 660 nm, and the widerange temperature control to develop an assay measuring intracellular calcium-induced fluorescence in response to temperature changes.
Temperature activation cell-based assay
One day prior to the experiment, cells were plated in a poly-L-lysine-treated optical 384-well plate (Applied Biosystems 4309849) at a concentration of ≈1000 cell/20 µl/well using a Labsystems multidrop. When plating the induction medium, DMEM supplemented with 10% FBS containing 0.1 µg/ml doxycycline (Sigma-Aldrich D9891) was used, replacing the maintenance medium to induce ion channel expression.
On the day of the experiments, the induction cell-culture medium was removed from the plates by gentle inversion. A fresh FLUO-4 AM loading buffer was prepared prior to experiments, using 1 vial of 1 mg FLUO-4 AM (Molecular Probes F14202) dissolved by adding 200 µl DMSO (Fisher Scientific D128-4) containing 5% pluronic acid.
A loading solution of 20 µl Hanks Balanced Salt Solution (HBSS; w Ca 2+ /Mg 2+ ) assay buffer (GibcoBRL 14185-045) containing FLUO-4AM, at a final concentration of 4 µM, was added to each well using a Labsystems multidrop. The HBSS was supplemented with 10 mM D-glucose (BDH 1011744), 10 mM Hepes, and NaHCO 3 (7.5%; GibcoBRL 25080-060).
Plates were incubated at 37 °C in a humidified incubator with 5% CO 2 , for 30 min. The incubation was terminated by removing the loading buffer by inversion and washing the cells twice with HBSS assay buffer, leaving a residual 10-µl assay buffer. Compounds, Ruthenium Red (RuR; Sigma-Aldrich R2751), or capsazepine (Sigma C-191) were dissolved in DMSO and added in 10-log dilutions starting at 100 µM final concentration in wells.
Data analysis
Fluorescence counts at 525-nm wavelength were extracted from all individual wells, and an initial baseline reading at 25 °C was subtracted. Responses were normalized to maximal response (control wells). All data point determinations were performed in duplicate on separate plates on different days before a mean value was calculated, including error bars representing the standard error of the mean (SEM). When the SEM is less than the symbol size, the error bars are obscured in the graphs. Data, IC 50 values, and concentration response curves were analyzed using GraphPad Prism 4 (GraphPad Software, La Jolla, CA).
RESULTS AND DISCUSSION
To verify that the system can be used to screen temperaturegated ion channels, we first tested the activation of rat and human TRPV1 expressed in HEK293 cells. Cells expressing either human or rat TRPV1 were incubated with the fluorescent calcium indicator dye, FLUO-4 AM, and exposed to a ramp of increasing temperature from 25 °C to 64 °C. The intracellular calcium concentration ([Ca 2+ ] i ) was measured on the instrument by detecting the fluorescence changes in response to the temperature change. In line with previous reports, 1, 9, 13, 14 both rat and human TRPV1-expressing cells show a rapid increase in [Ca 2+ ] i when the temperature rises above 40 °C, reaching a plateau at ∼48 °C. In the absence of extracellular calcium ([Ca 2+ ] o ), the increase in [Ca 2+ ] i is indistinguishable from HEK293 cells not expressing TRPV1 ( Fig. 1A and B) .
To validate TRPV1 pharmacology in this assay format, we used a step change from 25 °C to 48 °C ( Fig. 2A) . We selected the well-characterized TRPV1 antagonists capsazepine and RuR 9, 10, 14, 15 to block the heat-evoked responses in the rat and human TRPV1-expressing cell lines (Fig. 2B, C, and D) . The results are in good agreement with previous findings, showing that capasazepine is a more effective inhibitor of human TRPV1 noxious heat activation than rat TRPV1 (Fig. 2D) . 9 Similarly, RuR was as shown previously an equally effective inhibitor of both rat and human TRPV1 activation (Fig. 2C) . 10, 15 Next, we tested cold-evoked TRPA1 and TRPM8 responses. Figure 3A shows the increase in fluorescence from [Ca 2+ ] i in CHO cells expressing human TRPA1 and HEK293 cells expressing human TRPM8 in response to a decreasing temperature ramp from 25 °C to 6 °C.
The TRPA1-expressing CHO cells showed significantly larger cold responses upon cooling below ∼18 °C than the parental CHO cells not expressing TRPA1. Likewise, cooling of the TRPM8expressing HEK293 cells results in a nonlinear increase of the [Ca 2+ ] i from temperatures below ∼22 °C. Interes tingly, cooling ramps also elicited a nonlinear increase of the [Ca 2+ ] i between 22 °C and 6 °C in wild-type HEK293 cells not expressing TRPM8 (Fig. 3A) . From these observations, we conclude that TRPA1 CHO cells are better suited for concentration response experiments and pharmacological validation using temperature gating below room temperature. Analogously with previous work, we found that RuR is an effective inhibitor of TRPA1 activation (Fig. 3B, C) . 8 Primary afferent sensory DRG neurons are capable of detecting and discriminating thermal stimuli ranging from noxious cold to noxious heat. 6 Because the Thermo-TRPs are expressed in DRGs, we determined whether this assay could be used to detect temperature responses in a culture of isolated DRG neurons. The high sensitivity of the ABI Prism  7900HT Sequence Detection System enables the use of few cells per well (∼1000) and is therefore applicable even with primary cell preparations in which cell number is a limiting factor. Temperature ramps ranging from 25 °C to 64 °C elicited a marked increase of the [Ca 2+ ] i in isolated DRG neurons. Two distinct phases of the heating-evoked responses in DRG neurons were observed. The 1st phase between 45 °C and 55 °C, and the 2nd phase for temperatures greater than 55 °C, reaching a maximum at about 64 °C (Fig. 4) . The heat-activated Thermo-TRPs, TRPV1-V4 belonging to the TRPV subfamily, are expressed in DRG neurons. 2 Our results suggest that TRPV1 and TRPV2 could be responsible for the heat-evoked 1st-and 2nd-phase responses in the DRGs, respectively. To test this hypothesis, we ran similar experiments in the presence of the TRPV1 antagonist capsazepine or the nonspecific TRPV ion channel blocker, RuR. As expected, capsazepine was an effective blocker of the 1st-phase heat-evoked response for the temperature ranging from 45 °C to 55 °C but had no effect above 55 °C. Moreover, RuR inhibited both phases of the heat-evoked response along the whole temperature range tested (data not shown).
In summary, the observed pharmacological properties and temperature thresholds of activation for rat and human TRPV1, TRPM8, and TRPA1 in our assays are consistent with previous reports. 6 It has been reported that antagonists of multiple modes of TRPV1 activation as well as TRPV1 tonic activation cause hyperthermia. 3 Based on the temperature activation threshold, TRPV1 should be inactive at a normal body temperature. 2 Only a phenomenon of sensitization in abnormal conditions could link TRPV1 activity with temperature activation at normal body temperature. It is therefore reasonable to hypothesize that other modes of activation than temperature are responsible for tonic TRPV1 activity. Antagonizing them may be the cause of hyperthermia, stressing the necessity to test temperature activation modulation by new Thermo-TRP ligands. In previous published studies, novel antagonists have been discovered by high-throughput screening of compound libraries based on the use of agonist compounds (chemical ligands) or binding assays. These assay formats display limited ability to gate Thermo-TRP in a physiological relevant manner and differentiate specific block of noxious temperature activation. 7-10 Clearly, the specific temperature profile should be delineated by the next generation of selective Thermo-TRP antagonists.
In a recent paper, published during the preparation of this article, a custom-designed temperature-altering device was used to control temperature across a 384-well plate with optical readout in a fluorescence imaging plate reader. 12 Like in the present study, a significant aspect is the development of a temperature assay based on a 384-well plate array. However, the assay described herein is taking advantage of an existing technology for real-time PCR assays without any additional hardware modifications or investments. In addition to an accurate, rapid, and very wide-range temperature control, the TaqMan-based assay offers another advantage: The sensitivity of the system allows experiments to be carried out with a very low number of cells per well, enabling the development of fluorescence-based assays on primary cells, such as DRG neurons (Fig. 4) , which still remains a challenge in drug discovery screening today.
CONCLUSION
Taken together, our data confirm that this assay format allows pharmacological characterization of temperature activation of Thermo-TRP ion channels in both heterologous expression systems and DRGs with medium throughput. Development of 384-well microplate-based assay methods for screening Thermo-TRPs against temperature activation will certainly facilitate the design of compounds antagonizing or modulating ] o ), as indicated above the columns. Human TRPV1 (hTRPV1 red), rat TRPV1 (rTRPV1 blue), wild-type HEK293 (Hek wt black,) and buffer only (buffer gray). Data points and error bars represents average values and ±SEM, respectively, of several wells from at least 2 separate experimental days. 
